 |
 |

Treatment of Atypical Depression With Cognitive Therapy or Phenelzine
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
The syndrome of atypical depression is often characterized by a particularly chronic, recurrent course.1 It is interesting to speculate whether cognitions related to interpersonal rejection sensitivity, in addition to primary depressogenic cognitions, contribute to this chronicity. The finding of Jarrett et al2 that cognitive-behavioral therapy is an effective acute treatment for atypical depression is thus of great theoretical and practical interest. The 24-month follow-up should shed further light on potential long-term benefits of cognitive-behavioral therapy for this often refractory population.
Notwithstanding the impressive design of their study, 2 issues may significantly affect the interpretation and generalizability of the results. The first issue relates to the study sample itself. As noted by the authors, 287 individuals with major depression were recruited as possible subjects, with an astounding 242 (84%) meeting criteria for atypical depression. This rate not only belies the term atypical depression, but is also highly different from that . . . [Full Text of this Article]
|